SYRMA — Stage 2 setup with EFS 72.2 and investment score 91.3.
Separate the company from the entry: business quality first, timing second.
The edge is in staying with strong fundamentals — and demanding a sane entry.
SYRMA combines the latest available financial extract with the technical snapshot. Latest quarter: revenue 1,589 Cr (YoY +68.3%), PAT 106 Cr (YoY +112.0%). The next step is to reconcile these headline numbers with the annual report, exchange filings, and cash-flow quality.
Agent Adda scores from snapshot (stage_snapshot). Useful ranking signals — not standalone buy/sell rules.
EFS 72.2 is the composite fundamental score: it indicates a reasonably strong combination of earnings quality (69.0), sales growth (76.7), financial strength (73.8), and institutional bias (71.0). The weaker sales-growth/financial-strength components are why the score is not a clean quality signal. Investment Score 91.3 is higher because it blends the fundamental stack with the current technical setup, where the technical score is 93.5. In plain English: the tape is stronger than the balance-sheet evidence, so the stock can screen well for momentum without removing execution, leverage, or valuation risk. Validate the scores against audited cash flow, debt, margins, dilution, and the next two quarters before treating them as conviction.
Company overview from the available fundamentals extract; source gaps are stated rather than filled with scraper metadata.
The source extract did not return a reliable business description; use the linked exchange and annual-report sources before forming a business view.
Website evidence coverage gap
/company-index SYMBOL --website URL (or in company_intel.companies) and rerun deep research.5 annual periods returned from the fundamentals extract. The latest available annual period shows revenue +27.3% and PAT +88.0% versus the prior period; confirm whether the change is organic, margin-led, or acquisition-led in the annual report.
| Period | Revenue | Op. Profit | OPM | PAT | EPS | Payout |
|---|---|---|---|---|---|---|
| Mar 2022 | 1,267 | 129 | 10 | 79 | 5.59 | 0 |
| Mar 2023 | 2,048 | 192 | 9 | 123 | 6.75 | 22 |
| Mar 2024 | 3,154 | 203 | 6 | 124 | 6.04 | 25 |
| Mar 2025 | 3,787 | 323 | 9 | 184 | 9.53 | 16 |
| Mar 2026 | 4,819 | 546 | 11 | 346 | 16.48 | 9 |
6 quarterly periods are available. Jun 2026 revenue was 1,589 Cr and PAT 106 Cr; the latest sequential change was revenue +8.5% and PAT -10.9%. Use the next filing to test whether the latest growth rate is recurring and whether operating margin and cash conversion are moving with earnings.
| Quarter | Revenue | Op. Profit | OPM | PAT | EPS |
|---|---|---|---|---|---|
| Mar 2025 | 924 | 108 | 12 | 71 | 3.67 |
| Jun 2025 | 944 | 87 | 9 | 50 | 2.79 |
| Sep 2025 | 1,146 | 115 | 10 | 66 | 3.33 |
| Dec 2025 | 1,264 | 159 | 13 | 110 | 5.33 |
| Mar 2026 | 1,465 | 174 | 12 | 119 | 5.25 |
| Jun 2026 | 1,589 | 162 | 10 | 106 | 5.19 |
3 balance-sheet/cash-flow periods are available. Latest reported borrowings are 400 Cr, CFO is 290 Cr, and FCF is 114 Cr. Read these alongside PAT, working-capital movements, capex, and financing flows: profit growth is higher quality when it converts to operating cash without repeated debt or equity funding.
| Balance sheet item | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Equity Capital | 177 | 178 | 193 |
| Reserves | 1,435 | 1,572 | 2,670 |
| Borrowings+ | 630 | 665 | 400 |
| Total Liabilities | 3,688 | 4,202 | 5,767 |
| Fixed Assets+ | 1,075 | 1,144 | 1,458 |
| Total Assets | 3,688 | 4,202 | 5,767 |
| Cash flow item | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| CFO | -109 | 176 | 290 |
| CFI | -9 | -103 | -736 |
| CFF | 150 | -71 | 558 |
| FCF | -446 | 4 | 114 |
| Net Cash | 32 | 2 | 111 |
Evidence reviewed: 8 concall artifacts and 6 exchange/company announcements — PDF text extracted and synthesised by GPT-4o. The read-through below distinguishes reported numbers, management claims, and checks required before relying on the catalyst.
Newest exchange filings + extracted highlights (verify the source PDF/XBRL before thesis).
No NSE evidence digest available for this run.
BSE PDF, 414 pages, FY 2025-26 📄 View Annual Report PDF
| Turnover | ₹43,672 Cr |
| Borrowings | 2,284.40 |
| Dividend / Share | 1.50 |
Not extracted by the quick-scan pass — see the Annual Report Deep-Read Summary below for the page-by-page findings.
Not extracted by the quick-scan pass — see the Annual Report Deep-Read Summary below for the page-by-page findings.
Not extracted by the quick-scan pass — see the Annual Report Deep-Read Summary below for the page-by-page findings.
Syrma SGS Technology Limited's annual report for the fiscal year ending March 31, 2026, highlights significant growth in revenue and profit, strategic expansions, and a strong focus on sustainability and innovation. The company achieved a 27% increase in revenue, driven by growth in exports and the Original Design Manufacturing (ODM) business. Syrma SGS Technology also made strategic investments, including a 60% stake in Elcome Integrated Systems Private Limited, and improved its credit rating from AA- to AA. The report emphasizes the company's commitment to reducing greenhouse gas emissions and enhancing its employee satisfaction score. Financial statements were prepared in accordance with Indian GAAP, and the auditors expressed an unqualified opinion on both standalone and consolidated financial statements.
This card uses the separate annual-report deep-dive pipeline, not the lightweight field extractor. Source artifact: /Users/pradeepgorai/Documents/Projects/finance/Unified-NSE-Analysis/reports/latest/annual_report_deep_dive_SYRMA_ar_SYRMA_403b0c6bae6f.json.
Sector and peer claims are shown only when a same-date comparable dataset is available.
| Lens | Read-through |
|---|---|
| Sector | Not available |
| Data quality | No peer ranking asserted without comparable same-date observations. |
| Next check | Compare growth, margins, balance-sheet risk, valuation, and relative strength with the company’s listed peers. |
Peer ranking omitted: no comparable same-date peer dataset was supplied, so this report does not manufacture a self-comparison row.
EOD chart from PostgreSQL market.equity_eod (130 bars). Range: 2026-03-12 → 2026-09-16.
Technical setup from cached snapshot (if available).
| Indicator | Value | Note |
|---|---|---|
| Stage | Stage 2 | Weinstein stage |
| Signal | — | Snapshot |
| RSI | 54.21 | Momentum |
| ADX | 30.4 | Trend strength |
| SMA20/50/200 | 1503.5 / 1445.44 / 1052.69 | Trend context |
| Supertrend | SELL | Trend filter |
| Ratio | Value |
|---|---|
| Market cap | INR 31,576 Cr |
| P/E | 85.0x |
| ROCE | 16.8% |
| ROE | 14.0% |
| Book value | INR 148 |
| High / Low | 1660.0 / 634.5 |
| Dividend yield | 0.10% |
The snapshot labels the stock Stage 2 (Stage 2 uptrend). Weinstein stage describes the position of price within a multi-month trend: Stage 1 is a base, Stage 2 an advance, Stage 3 a topping range, and Stage 4 a decline. It is a context framework, not a forecast or standalone trade signal.
Evidence check: price is above the 20/50/200-day averages, and the moving averages are stacked bullishly (1503.5 / 1445.44 / 1052.69). RSI is 54.21 (neutral); ADX is 30.4 (strong trend); Supertrend is SELL. A bullish stage with weak momentum, a broken moving-average stack, or a conflicting Supertrend reading is a lower-quality setup.
Practical conclusion: watchlist-quality setup only when earnings acceleration, leadership, volume, and a definable risk point align.
Broker/analyst evidence is shown only when dated source results are returned.
Illustrative valuation from TTM EPS and P/E multiples (not a recommendation). The current multiple is exceptionally high; this is a sensitivity table, not a fair-value estimate, and small EPS or multiple changes materially affect the result.
| Scenario | TTM EPS | P/E | Implied value | vs current | Condition required |
|---|---|---|---|---|---|
| Bear (multiple compression) | 16.48 | 59x | 981 | -40% | Risk-off, slower growth, lower multiple. |
| Base (current multiple) | 16.48 | 85x | 1401 | -14% | Steady execution; multiple holds. |
| Bull (multiple expansion) | 16.48 | 102x | 1681 | +3% | Sustained growth + quality premium. |
Generic risk framework; replace with annual-report-specific risks when the report is parsed.
| Risk | Why it matters | Severity | What to monitor |
|---|---|---|---|
| Demand / earnings | Cyclicality, customer concentration, or weak volume can make recent growth non-recurring. | Medium | Orders, volume, segment mix, and next two quarters. |
| Working capital | Receivables and inventory can absorb cash even when accounting profit rises. | Medium | CFO versus PAT, working-capital days, and FCF. |
| Leverage / capex | Debt-funded expansion increases fixed obligations and execution risk. | Medium | Borrowings, interest cover, capex milestones, and funding source. |
| Governance / disclosure | Related parties, auditor remarks, pledges, or inconsistent reporting can change the thesis. | Medium | Annual-report notes, exchange filings, auditor qualifications, and dilution. |
| Valuation / entry | A good business can still deliver poor returns when expectations are already high. | Medium | Earnings delivery, peer multiples, trend support, and risk point. |
Source-first trail for review.